4//SEC Filing
SHULMAN JOHN D 4
Accession 0001567619-21-018515
CIK 0001815903other
Filed
Oct 20, 8:00 PM ET
Accepted
Oct 21, 8:47 AM ET
Size
36.2 KB
Accession
0001567619-21-018515
Insider Transaction Report
Form 4
JCP III SM AIV, L.P.
10% Owner
Transactions
- Purchase
Warrant
2021-10-18+1,661,807→ 1,661,807 total(indirect: See Footnote)Exercise: $1.72From: 2021-10-18Exp: 2026-10-18→ Common Stock (1,661,807 underlying) - Purchase
Common Stock, par value $0.0001 per share
2021-10-18$1.72/sh+1,661,807$2,849,999→ 5,057,771 total(indirect: See Footnote)
Juggernaut Partners III GP, Ltd.
10% Owner
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2021-10-18$1.72/sh+1,661,807$2,849,999→ 5,057,771 total(indirect: See Footnote) - Purchase
Warrant
2021-10-18+1,661,807→ 1,661,807 total(indirect: See Footnote)Exercise: $1.72From: 2021-10-18Exp: 2026-10-18→ Common Stock (1,661,807 underlying)
SHULMAN JOHN D
Director10% Owner
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2021-10-18$1.72/sh+1,661,807$2,849,999→ 5,057,771 total(indirect: See Footnote) - Purchase
Warrant
2021-10-18+1,661,807→ 1,661,807 total(indirect: See Footnote)Exercise: $1.72From: 2021-10-18Exp: 2026-10-18→ Common Stock (1,661,807 underlying)
METP Holdings LLC
10% Owner
Transactions
- Purchase
Warrant
2021-10-18+1,661,807→ 1,661,807 total(indirect: See Footnote)Exercise: $1.72From: 2021-10-18Exp: 2026-10-18→ Common Stock (1,661,807 underlying) - Purchase
Common Stock, par value $0.0001 per share
2021-10-18$1.72/sh+1,661,807$2,849,999→ 5,057,771 total(indirect: See Footnote)
Juggernaut Partners III GP, L.P.
10% Owner
Transactions
- Purchase
Common Stock, par value $0.0001 per share
2021-10-18$1.72/sh+1,661,807$2,849,999→ 5,057,771 total(indirect: See Footnote) - Purchase
Warrant
2021-10-18+1,661,807→ 1,661,807 total(indirect: See Footnote)Exercise: $1.72From: 2021-10-18Exp: 2026-10-18→ Common Stock (1,661,807 underlying)
Footnotes (2)
- [F1]See Note (1) in Exhibit 99.1.
- [F2]Includes 185,414 shares of Common Stock previously held of record by Metuchen Therapeutics, LLC ("MT") that were received by JCP III SM AIV, L.P. as a liquidating distribution. In prior reports, the reporting persons beneficially owned the 185,414 previously held by MT.
Documents
Issuer
Petros Pharmaceuticals, Inc.
CIK 0001815903
Entity typeother
Related Parties
1- filerCIK 0001208886
Filing Metadata
- Form type
- 4
- Filed
- Oct 20, 8:00 PM ET
- Accepted
- Oct 21, 8:47 AM ET
- Size
- 36.2 KB